title: Nivolumab for recurrent or metastatic head and neck cancer.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Tanday
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality / Q000556:secondary; D006801:Humans; D009364:Neoplasm Recurrence, Local; D000077594:Nivolumab; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000074322:Antineoplastic Agents, Immunological; D000077594:Nivolumab